Nanjing Ningdan New Drug Technology
A company developing new drugs for central nervous system diseases.
Launch date
Market cap
-
Enterprise valuation
€100—150m (Dealroom.co estimates Feb 2023.)
China (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
* | CNY200m | Series A | |
* | N/A | Early VC | |
| Total Funding | €25.0m | ||